Preferences for prenatal diagnosis and ethics in Japan by 森 剛志 & Takeshi Mori
KONAN UNIVERSITY
Preferences for prenatal diagnosis and ethics
in Japan
著者（英） Takeshi Mori
journal or
publication title
Konan economic papers
volume 60
number 1・2
page range 83-96
year 2019-09-30
URL http://doi.org/10.14990/00003378
(83) 83
甲南経済学論集第60巻第 1・2号 2019年９月
Takeshi Mori
Preferences for prenatal diagnosis
and ethics in Japan
Abstract
The prevalence of Down’s disease fetuses increases as late births dominate.
This trend can be found anywhere in developed countries. The number of people
who are interested in non-invasive preliminary testing (NIPT) is rapidly increas-
ing around the world. This paper investigated the preferences and ethical values
of unmarried Japanese men and women in their teens and early 20s about the use
of new prenatal diagnosis. Contingent valuation method (CVM) was used to in-
vestigate the willing to pay (WTP) of the younger generation for NIPT. The re-
sult showed the medium WTP is 140,000 yen for NIPT. There is a view that a
new prenatal diagnosis is regarded as the remarkable advances in reproductive
technology. On the other hand, it is criticized as the selection of life. If the po-
tential demands for prenatal diagnosis increase, there is not enough supply in
Japan to cope with it. Previous studies on prenatal diagnosis in developed coun-
tries were reviewed and information was collected that could be used as a refer-
ence for future ethical issues.
Keyword: non-invasive prenatal testing (NIPT), Contingent Valuation
Method (CVM), down syndrome, prenatal diagnosis, ethics
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1. Introduction
Non-invasive preliminary testing (NIPT) has been attracting interests world-
wide in recent years (Haidar, Dupras, & Ravitsky, 2016). The background is the
age at which women bear children is rising. Table 1 shows the change in the
number of births by female age in Japan. The numbers in bold indicate the age
class with the highest number. The table shows that the late 20’s were the larg-
est age group producing children by the year 2000, but the early 30’s were the
largest after 2005. This kind of elderly birth is a phenomenon that can be found
anywhere in developed countries. Table 2 summarizes the fertility rates by age
of women in major countries. In most developed countries, except for some
countries such as Russia, the United States and France, it can now be seen that
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Table 1 Trends in the number of babies born by women’s age group ( Japan)
year
Total
numbers
15～19
years old
20～24 25～29 30～34 35～39 40～44 45～49
1950 2,337,507 56,365 624,797 794,241 496,240 278,781 81,953 4,524
1955 1,730,692 25,219 469,027 691,349 372,175 138,158 33,055 1,706
1960 1,606,041 19,739 447,097 745,253 300,684 78,104 14,217 942
1965 1,823,697 17,719 513,645 854,399 355,269 72,355 9,828 480
1970 1,934,239 20,177 513,172 951,246 358,375 80,581 9,860 548
1975 1,901,440 15,999 479,041 1,014,624 320,060 62,663 8,727 319
1980 1,576,889 14,590 296,854 810,204 388,935 59,127 6,911 258
1985 1,431,577 17,877 247,341 682,885 381,466 93,501 8,224 245
1990 1,221,585 17,496 191,859 550,994 356,026 92,377 12,587 224
1995 1,187,064 16,112 193,514 492,714 371,773 100,053 12,472 414
2000 1,190,547 19,772 161,361 470,833 396,901 126,409 14,848 402
2005 1,062,530 16,573 128,135 339,328 404,700 153,440 19,750 598
2010 1,071,304 13,546 110,956 306,910 384,385 220,101 34,609 792
2015 1,005,675 11,929 84,461 262,256 364,870 228,293 52,558 1,308
2017 946,065 9,898 79,264 240,933 345,419 216,938 52,101 1,512
Source : National Institute of Population and Social Security Research Latest Demographic
Statistics, ‘Trends in the number of babies born by women’s age group’
the early thirties are the largest generations for children. As late births domi-
nate, the birth probability of Down’s fetus increases.
The NIPT is a new prenatal diagnosis that examines fetal DNA to find chromo-
somal abnormalities that cause Down syndrome, and it has quickly spread world-
wide soon after its introduction to clinical practice in Hong Kong in August 2011
and subsequently in the United States in October 2011 (Chiu & Lo, 2012). The
burden on pregnant women is negligible because a prenatal diagnosis can be eas-
ily done just by collecting blood. With advances in genetic diagnostic technology
and an increase in older births, the need for new prenatal diagnosis to check if
the fetus has Down syndrome is now rapidly growing in every developed country
(Minear, Lewis, Pradhan, & Chandrasekharan, 2015).
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Table 2 Fertility rate by age of women in major countries
Country /
region
year Total
birth
rate
Fertility rate of women by age (パーミル)
～19
years
old
20～24 25～29 30～34 35～39 40～44 45～49
Hong Kong 2017 0.9 2.6 15.7 45.9 64.8 41.5 9.2 0.5
Korea 2017 1.04 1.1 9.6 46.9 96.6 47.1 6.1 0.2
Spain 2016 1.32 7.4 25.6 56.5 91.3 65.4 16.5 1.3
Singapore 2017 1.33 2.7 15.8 69.1 110.3 57.3 10.6 0.6
Italy 2016 1.34 4.8 27.8 66.2 91.9 59.9 15.6 1.3
Japan 2017 1.42 3.5 27.5 82.1 102.2 57.5 11.4 0.3
Canada 2016 1.54 8.4 37.6 87.6 107.6 56 11.5 0
Switzerland 2016 1.56 2.8 27.3 80 115.5 70.2 14.7 0.9
Russia 2011 1.59 25.2 85.1 101.2 68.6 31.8 6.3 0.3
Germany 2016 1.6 9.2 39.3 87 109.6 62.3 12.2 0.5
Netherlands 2016 1.67 3 28.2 100 130.6 61.9 9.9 0.4
Norway 2016 1.71 3.9 39.6 107.3 119.4 59.1 11.7 0.7
Denmark 2016 1.78 3.5 35.3 114.4 129.6 61.4 11.5 0.6
UK 2016 1.79 13.7 54.7 97.4 111.2 66.3 14.4 0.9
Australia 2016 1.79 10.4 44.6 91.9 123.4 71.9 15.3 1.2
USA 2015 1.84 22.3 76.8 104.3 101.5 51.8 11 0.8
Sweden 2016 1.86 4.4 43.1 111.6 127.4 69.3 15 0.9
France 2012 1.99 9.4 58.2 131 127.2 59.1 12.9 0.7
Source : National Institute of Population and Social Security Research Latest Demographic
Statistics,’ Fertility rate by age of women in major countries’
A number of obstetrics and gynecology societies around the world have rec-
ommended that genetic counseling be set up for new prenatal diagnosis so that
families can make informed reproductive choices for diagnosis (Petersen, et al.,
2014). As a new prenatal diagnosis is adopted extensively, there is a risk of life
screening. Close attention must be paid to the provision of fetal gender informa-
tion, especially in areas where gender abortion is taking place. However, govern-
ments will have to establish a legal framework to implement regulation and
oversight. With the advancement of reproductive technology and genetic infor-
mation, the United States and many other developed countries have put in place
budgets and legislation to consider the ethical issues involved (Allyse, et al.,
2015). On the other hand, the current situation in Japan is almost left untouched.
So to speak, its national understanding and legal development have not kept pace
with technological advances.
The current paper analyzes the preferences for and understandings of NIPT of
the Japanese younger generation and makes use of the survey as a source for ex-
amining what matters should be considered in order to develop the ethical and
legal systems.
The conventional blood test for prenatal diagnosis is a test that measures
blood protein concentration by collecting a small amount of blood from a pregnant
woman, such as quattro test and triple marker test. This test had poor diagnostic
accuracy and a 27％ chance of making a diagnostic error (Russo & Blakemore,
2014 ; Shamshirsaz, Benn, & Egan, 2010). Another conventional method of pre-
natal diagnosis is amniotic fluid test. The amniotic fluid is collected from the
belly of a pregnant woman, and the test method to determine the shape and num-
ber of chromosomes is high in test accuracy, but it can be diagnosed only after
15 weeks of pregnancy, and there is a risk of abortion with a probability of
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1～2％ (Norwitz & Levy, 2013). An error in diagnosis may lead to the decision
to end the life originally born to the parents based on the diagnostic information.
The new prenatal diagnosis is expanding its economic market. The global mar-
ket size for prenatal diagnosis was estimated to be about 20 billion yen in 2011,
but it is estimated to reach about 3,620 billion yen in 2019. As for 2011, only a
few companies around the world had started offering new prenatal diagnoses, but
they are now available in more than 60 countries. North America accounts for
64.5％ of total revenue, followed by Europe (Allyse, et al., 2015). The diagnostic
price varies from country to country : about 80,000 yen to over 300,000 yen
($ 795over $ 3,000) in the United States, about 80,000 yen to 100,000 yen
(631858) in Europe, about 60,000 yen to 100,000 yen (US $ 580$ 1,000) in
Hong Kong (Chandrasekharan, Minear, Hung, & Allyse, 2014). The diagnostic
price is considered to play an important role when a patient decides whether to
accept.
It is also important to advance cost-effectiveness analysis. According to previ-
ous reports, in spite of a decrease in the number of invasive tests in Australia, a
chromosome test with 21 trisomy (Down’s syndrome) alone has shown an in-
crease of 9.7％ in cost over the past two years, and the increase trend also can
be found in the UK (Morris, Karlsen, Chung, Hill, & Chitty, 2014 ; O’leary,
Maxwell, Murch, & Hendrie, 2013). However, in the United States, using NIPT
as the first screening has been reported as cost effective (Ohno & Caughey,
2013). In Japan, appropriate cost-benefit analysis will be awaited as the number
of new prenatal diagnosis practices increases.
2. Ethics and legal regulations
New prenatal diagnosis involves the selection of life, and ethical discussions
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are essential. Currently, in developed countries around the world, expert guide-
lines recommend that patients undergo genetic counseling before and after new
birth diagnosis (Allyse, et al., 2015). In the United States, there is much provi-
sion of NIPT, and 94％ of the 278 US specialists surveyed are reported to recom-
mend NIPT (Haymon, Simi, Moyer, Aufox, & Ouyang, 2014). It is expected to
increase in Japan in the future.
Until now, medical institutions that can provide new prenatal diagnosis in
Japan have been limited to facilities with obstetricians, pediatrics and experi-
enced genetic specialists for outpatients. However, the Japan Obstetrics and
Gynecology Society has accepted the plan that any obstetrician who has received
training on new prenatal diagnosis can provide a prenatal diagnosis test, and
clarified the policy to expand facilities that can provide new prenatal diagnosis
significantly. (March 2019). If new prenatal diagnosis is to be widely used in the
future, it will be necessary to deeply consider ethical issues on both the demand
and supply sides of the diagnosis.
For the people who are on the demand side, the country should consider the
ethical issues of the new prenatal diagnosis and analyze the people’s preferences
in order to ensure fair use that does not revert to eugenic concepts. Unless the
patient is presented with clear guidelines for selection, they may not be given the
opportunity to think about whether they should receive NIPT and how to re-
spond to the outcome of the diagnosis (Van Schendel, et al., 2014). In the case
of collecting blood from pregnant women, it is necessary to strengthen the prac-
tices of informed consent and monitoring so that new prenatal diagnosis cannot
be routinely incorporated at medical institutions on the supply side.
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3. Survey results on ethics
A questionnaire related to the new prenatal diagnosis was conducted from
April to June 2019 for 211 unmarried men and women in their teens and 20s.
The average age is 18.6 years, and the ratio of women is 41.2％.
Specifically, we asked about the extent of “accepting the examination” in some
practical situations. The questionnaire contents and results will be shown se-
quentially.
◆◆ Questionnaire ◆◆ ～ prenatal genetic testing ～
Now genetic testing of humans is able to read all genes. As for more than
40 years old mothers, one in fifteen children is born with down’s syn-
drome, but it can also be understood in advance only by the blood test of
pregnant women (‘new type prenatal (genetic)’ test) for about 200,000
yen. Given this situation, answer the following questions :
Question 1: Which subsidy should be increased?
◆Program A◆ Subsidy for new type prenatal (genetic) testing
◆Program B◆ Subsidy for treatment and support for people with dis-
abilities
Question: Which do you think should be increased one of the two pro-
grams?
1. Program A (28.0％) 2. Program B (72.0％)
As a result, more than 70％ of the respondents endorsed “Program B: Grants
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for treatment and support for people with disabilities.” It can be interpreted that
there are more than 70％ of respondents who say that genetic testing does not
favor preventing the birth of Down’s fetus, but rather should accept and support
people with disabilities in society.
In addition, the following questionnaires that include other ethical issues will
be included with the results. As for the questionnaire, questions were asked
with four options : “I think so”, “I think so”, “I do not think so”, and “I do not
think so”. The former two options are summarized with “Yes” and the latter two
options with “No”.
The majority is against “mandating genetic testing to the people (Q2)”. It can
be said that the majority is opposed to the government’s health policy of inter-
vention. Although it can be accepted that it is against “eugenic thought”, 40％ of
respondents also accept national intervention. In addition, I think that more than
70％ of young people do not want to know “sex of their baby (Q3)”. Money may
be the bottleneck. In addition, (Q4) “Whether the baby’s gender should be
known in advance” states that over 90％ of respondents depend on their parents.
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Questions Yes No
Q2
It is acceptable for the government to require the pub-
lic to carry out genetic testing as a health policy.
44.1％ 55.9％
Q3
Even if I pay extra money, I want to know in advance
the sex of my baby.
28.9％ 71.1％
Q4
It is up to the parents to decide whether to know the
baby’s gender in advance.
94.3％ 5.7％
Q5
I think that genetic testing should be extended to all
fetuses.
37.9％ 62.1％
Q6
I think that it is not good that abortion after knowing
that the fetus has Down syndrome because it becomes
a selection of life.
55.9％ 44.1％
Furthermore, the majority opposes “should expand genetic testing to all fetuses
(Q5)”. This is in line with opposition to the interventions of the countries. The
majority of respondents disagreed with the direction of expansion of national ge-
netic analysis by the country.
In addition, the majority of the younger generation says that I don’t think it’s
a right thing to do because aborting is a selection of life (Q6). If we look at the
above points, it is fair to say that Japanese young people are against the interven-
tion of national genetic analysis. However, there are many who are opposed to
each other, and it can be determined that Japanese unmarried young people do
not have a firm understanding or idea of prenatal diagnosis. It can be said that
this is a natural result, considering that there is not enough public debate about
prenatal diagnosis.
The following questions were asked about what kind of meaning the new pre-
natal diagnosis has to society.
Q7 There should be various people in society. NIPT testing leads to dis-
crimination against people with disabilities. (Select one from 1 to 5).
The results are : “I think so (12.3％)”, “I think so (32.2％)”, “Neither (32.7
％)”, “I do not think so (15.6％)”, “ I do not think so (7.1％). About half say
that “new-type prenatal (genetic) testing leads to discrimination against people
with disabilities.” The younger people perceive the development of medical
technology as a danger rather than accept and enjoy it. It can be understood that
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1. I agree (12.3％) 5. I disagree (7.1％)3. Neutral (32.7％)
2. I agree if anything (32.2％) 4. I disagree if anything (15.6％)
the spread of genetic testing is considered to lead to discrimination. However,
it turns out that 30％ of young people answered that “neutral”, and there are
many people who do not have a firm opinion.
4. Contingent Valuation Method (CVM)
For respondents, a hypothetical situation is given : “A new type of prenatal di-
agnosis can be received at a cost of 10,000. Supposing your baby will be born,
would you like to use this test ?” And they were asked if the respondents will use
it. One of the following prices was presented to each respondent ; 30,000, 50,000,
100,000, 150,000, 200,000 yen.
The results are as shown in Table 3. The median was 140,000 yen. At pre-
sent, the cost of new type prenatal diagnosis in Japan is about 200,000 yen, but
it was found that the medium price is about 140,000 yen, about half of the young
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Table 3－1 Survey results for the use of NIPT
WTP Yes No
30,000 yen 38 10
50,000 yen 34 12
100,000 yen 27 14
150,000 yen 17 20
200,000 yen 14 25
Table 3－2 Estimation results by CVM
variable coefficient t value p value
constant 2.6253 5.121 0.000 ***
ln(Bid) 1.0066 4.519 0.000 ***
n 211
Log likelihood 129.17
Estimated WTP (yen)
(Medium) 140,000
people are willing to use the new type of test. Figure 1 shows the estimation re-
sults by the hypothetical evaluation method. If the price is 30,000 yen, it is un-
derstood that about 80％ of young people use the examination.
5. Discussions
This paper examines the preferences and ethical values of unmarried Japanese
men and women in their teens and early 20s in terms of prenatal diagnosis.
Despite the remarkable progress in reproductive technology, the results of this
survey did not show that the younger generation enjoy it, but rather consider it
as a risk. The public debates on genetic testing is not sufficiently conducted, and
the understanding and insight of young people is not solid.
The majority of participants opposed to the idea of “mandating genetic testing
to the public,” and of “extending genetic testing to all fetuses.” This can be
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Figure－1 Results by CVM
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Note : I made use of the program from the site of Pro. Koichi Kuriyama ‘CVM used by Excel
ver 3.2’. (http : // homepage1.nifty.com/kkuri /)
viewed as disliked the intervention for national genetic analysis. In addition,
70％ of young people say that they do not want to know about “sex of their
baby”. This is a very different view from India and China.
However, opinion is divided in several points, and it can not be said that they
have sufficient understanding and insight. The lowering in mothers’ age limits at
new prenatal diagnosis is considered premature. According to the virtual evalua-
tion method, it was found that about half of the young people are willing to use
if the new type prenatal diagnosis is 140,000 yen. However, sufficient public de-
bate corresponding to the technology is considered essential. It will be a future
task to conduct surveys to a wider audience of the people.
Appendix ～Questionnaire～
◆◆Prenatal genetic testing◆◆
Now genetic testing of humans is able to read all genes. One child with Down’s syndrome
is born in 15 old births older than 40 years old, but it can also be understood in advance
only by the blood test of pregnant women (‘new type prenatal (genetic)’ test) for about
200,000 yen. Answer the following questions :
Question 1 : Which subsidy should I increase?
◆Program A◆ Subsidy for new type prenatal (genetic) testing
◆Program B◆ Subsidy to treatment and support for people with disabilities
Question : Do you think you should increase one of the two programs?
1. Program A 2. Program B
94
I agree I agree if
anything,
I disagree if
anything,
I disagree
Q2 It is acceptable for the government to
require the public to carry out genetic
testing as a health policy.
1 2 3 4
Q3 Even if I pay extra money, I want to
know in advance the sex of my baby.
1 2 3 4
Q7 There should be various people in society. NIPT testing leads to discrimination
against people with disabilities. (Select one from 1 to 5).
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